145 related articles for article (PubMed ID: 7483142)
1. Biomodulation of 5-Fu cytotoxicity by folinic acid and its stereoisomers: in vitro experiments with different cell lines of prostatic cancer.
Breul J; Jakse G; Hartung R
Urol Res; 1995; 23(3):163-7. PubMed ID: 7483142
[TBL] [Abstract][Full Text] [Related]
2. Dual effects of folinic acid in 5-fluorouracil induced killing of human tumor cell lines in vitro.
Blomgren H; Edler D; Hallström M; Ragnhammar P
Anticancer Res; 1996; 16(5A):2713-7. PubMed ID: 8917376
[TBL] [Abstract][Full Text] [Related]
3. Fluorouracil combined with the pure (6S)-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study.
Machover D; Grison X; Goldschmidt E; Zittoun J; Lotz JP; Metzger G; Richaud J; Hannoun L; Marquet J; Guillot T
J Natl Cancer Inst; 1992 Mar; 84(5):321-7. PubMed ID: 1738182
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens.
Machover D; Grison X; Goldschmidt E; Zittoun J; Metzger G; Richaud J; Lotz JP; André T; Hannoun L; Marquet J
Ann Oncol; 1993; 4 Suppl 2():29-35. PubMed ID: 8353102
[TBL] [Abstract][Full Text] [Related]
5. Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitor.
Fischel JL; Formento P; Etienne MC; Spector T; Renée N; Milano G
Biochem Pharmacol; 1997 Jun; 53(11):1703-9. PubMed ID: 9264323
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer.
Voboril R; Hochwald SN; Li J; Brank A; Weberova J; Wessels F; Moldawer LL; Camp ER; MacKay SL
J Surg Res; 2004 Aug; 120(2):178-88. PubMed ID: 15234211
[TBL] [Abstract][Full Text] [Related]
7. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of 5-fluorouracil cytotoxicity by folinic acid in different cell-lines of human renal cell carcinoma.
Breul J; Tief G; Hartung R
Eur J Med Res; 1996 Apr; 1(7):339-42. PubMed ID: 9364036
[TBL] [Abstract][Full Text] [Related]
9. Lack of interference by the unnatural isomer of 5-formyltetrahydrofolate with the effects of the natural isomer in leucovorin preparations.
Bertrand R; Jolivet J
J Natl Cancer Inst; 1989 Aug; 81(15):1175-8. PubMed ID: 2787408
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and in vitro studies of l-leucovorin. Comparison with the d and d,l-leucovorin.
Zittoun J
Ann Oncol; 1993; 4 Suppl 2():1-5. PubMed ID: 8353099
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic rationale for fluoropyrimidine-leucovorin combination: biochemical mechanisms.
Zhang ZG; Rustum YM
Semin Oncol; 1992 Apr; 19(2 Suppl 4):46-50. PubMed ID: 1532459
[TBL] [Abstract][Full Text] [Related]
12. [Cytotoxic effects of the combination of a new nitrosourea, fotemustine, combined with 5-fluorouracil and folinic acid depend on the sequence of their administration].
Fischel JL; Formento P; Berlion M; Berille J; Gioanni J; Bizzari JP; Milano G
Bull Cancer; 1992; 79(1):81-90. PubMed ID: 1520955
[TBL] [Abstract][Full Text] [Related]
13. Wide range for optimal concentration of folinic acid in fluorouracil modulation--experimental data on human tumour cell lines.
Beck A; Etienne MC; Chéradame S; Fischel JL; Formento P; Guillot T; Milano G
Eur J Cancer; 1994; 30A(10):1522-6. PubMed ID: 7833112
[TBL] [Abstract][Full Text] [Related]
14. Effects of folinic acid on 5-fluorouracil induced cell lethality with or without cisplatin against head and neck laryngeal squamous carcinoma multicellular tumor spheroids.
Kohno N; Ohnuma T; Kawaida M; Kawasaki K; Ichikawa G
Acta Otolaryngol; 1992; 112(3):566-73. PubMed ID: 1441999
[TBL] [Abstract][Full Text] [Related]
15. Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines.
Fischel JL; Rostagno P; Formento P; Dubreuil A; Etienne MC; Milano G
Br J Cancer; 2001 Feb; 84(4):579-85. PubMed ID: 11207057
[TBL] [Abstract][Full Text] [Related]
16. Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data.
Fischel JL; Etienne MC; Formento P; Milano G
Clin Cancer Res; 1998 Oct; 4(10):2529-35. PubMed ID: 9796987
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous, But Not Consecutive, Combination With Folinate Salts Potentiates 5-Fluorouracil Antitumor Activity In Vitro and In Vivo.
Di Paolo A; Orlandi P; Di Desidero T; Danesi R; Bocci G
Oncol Res; 2017 Aug; 25(7):1129-1140. PubMed ID: 28109077
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-fluorouracil, leucovorin, and glucarate in rat colon-tumor explants.
Schmittgen TD; Koolemans-Beynen A; Webb TE; Rosol TJ; Au JL
Cancer Chemother Pharmacol; 1992; 30(1):25-30. PubMed ID: 1586977
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: a prospective randomized pilot trial.
Breul J; Jakse G; Forster G; Lampel A; Rohani A; Hartung R
Eur Urol; 1997; 32(3):280-3. PubMed ID: 9358213
[TBL] [Abstract][Full Text] [Related]
20. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.
Moran RG; Scanlon KL
Cancer Res; 1991 Sep; 51(17):4618-23. PubMed ID: 1831402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]